Moolec Science SA (MLEC)
1.68
-0.19
(-10.16%)
USD |
NASDAQ |
Oct 16, 16:00
1.57
-0.11
(-6.55%)
After-Hours: 20:00
Moolec Science Total Liabilities (Quarterly)
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2024 | 28.58M |
| September 30, 2024 | 26.87M |
| June 30, 2024 | 27.97M |
| March 31, 2024 | 19.31M |
| December 31, 2023 | 14.64M |
| September 30, 2023 | 13.60M |
| June 30, 2023 | 13.95M |
| March 31, 2023 | 8.395M |
| December 31, 2022 |
| Date | Value |
|---|---|
| September 30, 2022 | 4.419M |
| June 30, 2022 | 3.425M |
| March 31, 2022 | 3.464M |
| December 31, 2021 | 3.314M |
| September 30, 2021 | 3.417M |
| June 30, 2021 | 4.507M |
| March 31, 2021 | 2.936M |
| December 31, 2020 | 0.30M |
| September 30, 2020 | 0.1733M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Arcadia Biosciences, Inc. | 5.26M |
| Zivo Bioscience, Inc. | 3.826M |
| PMGC Holdings, Inc. | 19.83M |
| TFA Therapeutics, Inc. | -- |
| Archer-Daniels-Midland Co. | 29.66B |